Rising to the challenge of delivering precision medicines for chronic diseases
World Health Summit Regional Meeting 2022
Sapienza University, Rome, Italy
In this recording from the event, you will hear from both Co-Chairs from the World Health Summit and AstraZeneca. In addition, you will hear from expert panellists from Biopharma, Diagnostics and Government including AstraZeneca, Almac Diagnostic Services, Bristol Myers Squibb and Horizon Europe.
Title:
The title of the session is “Rising to the challenge of delivering precision medicines for chronic diseases.”
Themes:
Luciano Saso, World Health Summit
- Introduction to the session and the panel
Maria Orr, Astrazeneca
- Overview of precision medicine in chronic disease
- What does it take to deliver a precision medicine to the patient in chronic disease?
Stefano Vella, Health Cluster
- Is precision medicine needed in chronic diseases beyond oncology?
Richard Kennedy, Almac Diagnostic Services
- Co-development of a diagnostic alongside a drug requires a strong partnership
Claudia Dollins, Bristol Myers Squibb
- Use of diagnostics in trials and in treatment decision making is highly regulated & changing.
Maria Orr, Astrazeneca
- Final thoughts
Video Length
Just under 1 hr 30 mins
View Resource
Diagnostic Services
Your global partner for biomarker discovery, development & commercialisation.
Genomic Services
We offer a range of genomics platform and chemistry options, alongside expert data sciences support and a full sample management service.
Clinical Trial Assays
Comprehensive development, validation & delivery service for research and clinical use assays from our global clinical laboratories in USA, Europe and APAC.
Companion Diagnostics
A collaborative Companion Diagnostic partnership approach with a deep understanding of client needs. We offer CDx development, manufacture & commercialisation services.